Otsuka’s IV solutions subsidiary, Otsuka Pharmaceutical Factory, is breaking into the North American market with the help of ...

License Revenue: For the third quarter of 2024, license fees recognized from the securities purchase agreement with a European partner, supplemented by a binding term sheet, amounted to ... network as ...

Recent quality and operational issues at Smiths, which originated before it was purchased, greatly reduced ICU’s gross margin after the acquisition. These issues have required additional spending to ...

Since its initial public offering, Convatec has followed a familiar playbook to press its advantage in advanced wound care and to enhance its ostomy business. By and large, we like Convatec’s ...

In this conversation with Medline CEO Jim Boyle, he outlines the strategy health systems need to build a resilient supply ...

Drug shortages in the U.S. are increasing in number and duration, primarily affecting generic and multi-sourced drugs that ...

As the nation’s largest supplier of intravenous fluids works to return to full production in North Carolina, Self Regional ...

Insights from five case studies determining the benefits, challenges and potential of the drone transportation of medical ...